Sana Biotechnology, Inc. (SANA)

Sana Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	96.13	127.57	133.52	176.77	253.03	124.81
Short-Term Investments	8.57	24.93	71.68	247.2	297.97	253.46
Cash & Short-Term Investments	104.7	152.5	205.2	423.96	551	378.26
Cash Growth	-66.34%	-25.68%	-51.60%	-23.05%	45.66%	172.17%
Prepaid Expenses	3.84	4.48	4.49	14.37	7.11	6.2
Restricted Cash	4.2	3.83	3.83	6.1	-	-
Total Current Assets	112.73	160.81	213.52	444.44	558.1	384.47
Property, Plant & Equipment	128.52	135.27	145.59	159.4	161.78	109.94
Long-Term Investments	-	-	-	10.05	195.88	33.73
Goodwill	140.63	140.63	140.63	140.63	140.63	140.63
Other Intangible Assets	59.2	59.2	59.2	59.2	59.2	59.2
Other Long-Term Assets	4.39	5.12	6.37	9.01	13.82	2.33
Total Assets	445.47	501.02	565.3	822.72	1,129	730.3
Accounts Payable	0.99	5.21	4.11	2.86	2.22	2.25
Accrued Expenses	18.76	27.39	37.98	39.12	28.91	22.59
Current Portion of Leases	13.4	12.83	13.2	12.39	9.16	3.71
Other Current Liabilities	-	-	9.2	57.14	58.95	2.89
Total Current Liabilities	33.16	45.43	64.49	111.5	99.24	31.45
Long-Term Leases	85.61	89.06	90.9	95.86	101.78	68.2
Other Long-Term Liabilities	117.62	116.02	122.41	116.04	199.89	198.94
Total Liabilities	236.39	250.52	277.79	323.41	400.91	298.58
Common Stock	0.02	0.02	0.02	0.02	0.02	0
Additional Paid-In Capital	1,863	1,855	1,626	1,558	1,515	8.22
Retained Earnings	-1,654	-1,605	-1,338	-1,055	-785.36	-429.43
Comprehensive Income & Other	-	0.01	-0.06	-4.33	-1.37	0.03
Total Common Equity	209.08	250.5	287.51	499.32	728.5	-421.18
Shareholders' Equity	209.08	250.5	287.51	499.32	728.5	431.71
Total Liabilities & Equity	445.47	501.02	565.3	822.72	1,129	730.3
Total Debt	99.01	101.9	104.1	108.25	110.94	71.91
Net Cash (Debt)	5.69	50.6	101.1	325.76	635.93	340.09
Net Cash Growth	-97.23%	-49.95%	-68.97%	-48.77%	86.99%	272.57%
Net Cash Per Share	0.02	0.22	0.52	1.73	3.82	26.13
Filing Date Shares Outstanding	225.56	225.02	220.45	191.35	185.18	177.43
Total Common Shares Outstanding	225.46	223.92	197.86	191.02	184.93	16.17
Working Capital	79.58	115.38	149.03	332.93	458.87	353.02
Book Value Per Share	0.93	1.12	1.45	2.61	3.94	-26.05
Tangible Book Value	9.26	50.68	87.68	299.49	528.68	-621.01
Tangible Book Value Per Share	0.04	0.23	0.44	1.57	2.86	-38.40
Machinery	57.32	57.79	54.77	64.76	49	30.59
Construction In Progress	40.36	40.34	26.33	1.71	1.39	8.32
Leasehold Improvements	33.34	33.34	31.36	34.43	33.85	15.6

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q